{"rewrite":{"id":"r_eab3935ada97a989772ed307","clusterId":"c_09de1d3fdaab32a6bbca1a73","slug":"glp-1-weight-loss-drugs-linked-to-higher-alopecia-risk-study-finds","model":"deepseek-v4-flash:free","headline":"GLP-1 Weight Loss Drugs Linked to Higher Alopecia Risk, Study Finds","summary":"A University of Pennsylvania study compared over 50,000 type 2 diabetes patients and found GLP-1 receptor agonists like Ozempic and Mounjaro carry a 37% higher alopecia risk than SGLT2 inhibitors and 68% higher than DPP-4 inhibitors. The absolute risk remains low, with about 7 cases per 1,000 patients.","whyItMatters":"The study provides the first solid evidence linking widely used weight loss drugs to hair loss, giving patients and doctors a new factor to weigh in treatment decisions.","webCardHtml":"\u003cp\u003eThe study, published in The BMJ, used target trial emulation to compare patients who started GLP-1 receptor agonists with those on SGLT2 inhibitors and DPP-4 inhibitors. After adjusting for age, sex, ethnicity, and medical history, the association held. The research team noted that rapid weight loss has long been tied to hair loss, which may explain the effect. They stressed that the absolute risk is low but that awareness could inform treatment decisions.\u003c/p\u003e","blueskyPost":"New BMJ study: GLP-1 drugs like Ozempic and Mounjaro linked to 37-68% higher alopecia risk vs other diabetes meds. Absolute risk low, ~7 per 1,000. Rapid weight loss may be the cause.","twitterPost":"GLP-1 drugs (Ozempic, Mounjaro) tied to higher hair loss risk: 37% vs SGLT2 inhibitors, 68% vs DPP-4 inhibitors. Absolute risk low, ~7/1,000. Study in The BMJ.","threadsPost":null,"newsletterBlurb":"A new BMJ study links GLP-1 receptor agonists to a higher risk of alopecia. Compared to other diabetes drugs, the risk was 37% to 68% higher, though the absolute numbers remain low. Rapid weight loss may be the underlying cause.","attributionJson":"[{\"source\":\"GIGAZINE\",\"url\":\"https://gigazine.net/news/20260811-weight-loss-drugs-hair-loss-risk/\",\"title\":\"GLP-1 receptor agonists used for weight loss such as Mounjaro and Ozempic may increase the risk of 'baldness'\"}]","lintFlagsJson":null,"lintHits":0,"costUsd":0,"inputTokens":4688,"outputTokens":533,"status":"published","repairAttempts":0,"nextRepairAt":null,"factsAttemptedAt":1786454264,"createdAt":"2026-08-11T13:13:44.000Z","publishedAt":"2026-08-11T13:16:44.000Z","updatedAt":"2026-08-11T13:13:44.000Z"},"cluster":{"id":"c_09de1d3fdaab32a6bbca1a73","canonicalTitle":"マンジャロやオゼンピックなどダイエットに使われるGLP-1受容体作動薬は「ハゲ」のリスクを高める可能性","representativeArticleId":"a_a39474f91fbb5df75a2483a6","sourceCount":1,"writtenSourceCount":1,"writeAttempts":0,"isSolo":true,"entitiesJson":"{\"anime_titles\":[],\"manga_titles\":[],\"work_titles\":[],\"studios\":[],\"people\":[],\"type\":\"news\",\"domain\":\"other\",\"is_roundup\":false}","contentType":"news","status":"published","firstSeenAt":"2026-08-11T12:00:00.000Z","lastSeenAt":"2026-08-11T12:00:00.000Z","updatedAt":"2026-08-11T13:16:44.000Z"},"attribution":[{"source":"GIGAZINE","url":"https://gigazine.net/news/20260811-weight-loss-drugs-hair-loss-risk/","title":"マンジャロやオゼンピックなどダイエットに使われるGLP-1受容体作動薬は「ハゲ」のリスクを高める可能性"}],"entities":{"anime_titles":[],"manga_titles":[],"work_titles":[],"studios":[],"people":[],"type":"news","domain":"other","is_roundup":false},"keyFacts":null}